CITY-OF-TAMPERE
17.9.2022 16:01:36 CEST | Business Wire | Press release
Sara Hildén Art Museum in Tampere Finland is proud to present Thomas Houseago’s first exhibition in the Nordic countries. Thomas Houseago is a world-renowned artist. In the Tampere exhibition, Houseago is presenting his own sculptures and paintings alongside a ceramic series by Nick Cave and sculptures by Brad Pitt. Cave and Pitt are already renowned in their respective fields of music and cinema, but this is the first time ever they have exhibited their artwork pieces created during the course of an ongoing dialogue with Houseago.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220915005685/en/
Sara Hildén Art Museum in Tampere Finland presents Thomas Houseago’s first exhibition in the Nordic countries. Houseago is presenting his own sculpture and paintings alongside a ceramic series by Nick Cave and sculptures by Brad Pitt. The Exhibition opened on 17th September 2022. Museum Director Anna Hjorth-Röntynen, Nick Cave, Chief Curator Sarianne Saikkonen, Thomas Houseago, Mayor of Tampere Anna-Kaisa Ikonen and Brad Pitt. Photo: Jussi Koivunen
“I’m very happy and proud that Thomas Houseago decided to bring WE to Tampere. It is also exciting to get to experience a new and different artistic side of Nick Cave and Brad Pitt. WE delivers a strong message of working together, creating something new and a sense of community that is compatible with Tampere, as the city is known for its capacity for change and making bold decisions together. The message of doing together and relying on each other is very powerful in these turbulent times”, says Anna-Kaisa Ikonen, Mayor of Tampere.
In addition to the WE-exhibition at Sara Hildén, Tampere’s autumn and winter of art is plentiful and bright. Tampere Art Museum offers rarities from Finnish art foundations commencing on Oct 8th. The exhibition includes works by artists such as Helene Schjerfbeck, Ellen Thesleff, Fanny Churberg, Akseli Gallen-Kallela and Tyko Sallinen. The other museums of Tampere, for example Vapriikki, offer experiences for the whole family. Especially the Moomin Museum is a favourite of kids.
The Tampere Philharmonic plays beloved classics and new pieces. The brand new Nokia Arena will host exciting international concerts. Tampere is also the theatre capital of Finland, and the theatres of Tampere are full of great musicals, drama, comedy and crime stories.
Tampere has direct flight routes to many European destinations, for example to Amsterdam, Oslo, Malaga, Riga and München. It is also easily reached from the Finnish capital Helsinki, for example, the train ride from Helsinki to Tampere takes about 1,5 hours.
Thomas Houseago – WE with Nick Cave & Brad Pitt 18.9.2022 – 15.1.2023 at Sara Hildén Art Museum.
www.sarahildenintaidemuseo.fi, www.tampere.fi/en/international-tampere
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220915005685/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release
A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom